Research, Studies & Clinical Trials

Thank you for your interest in participating in a paid research study at University of Colorado OB-GYN. All clinical trials are conducted by a physician from CU OB-GYN.

Study: Pre-IVF treatment with a GnRH antagonist in women with endometriosis – A prospective double-blind placebo-controlled trial (PREGnant) (COMIRB 19-3115)

The purpose of this clinical research is to study the effects of Elagolix on IVF cycle(s) in women with endometriosis. Elagolix is Food and Drug Administration (FDA) approved for endometriosis, but not for use as a part of IVF care.

You may qualify if you are:

  • Between the ages of 18 and 40 years old.
  • Have a diagnosis of endometriosis.
  • Are seeking IVF care.

 If you are interested in learning more about this study, please contact [email protected] or [email protected]. You may also call Shannon at 303-724-5276 or Jamie at 603-714-9772.

Study: Outcomes of Menstrual Suppression in Adolescent Females with Developmental Disabilities (COMIRB 18-2427)

  If interested in participating can call the Pediatric and Adolescent Gynecology Clinic at 720-777-2667.

The aim of the study is to prospectively follow indications, clinical characteristics, and outcomes of patients with developmental disabilities receiving menstrual suppression in the pediatric and adolescent population at Children’s Hospital Colorado. Caregivers will receive surveys at 1, 3, 6, and 12 months after patients start menstrual suppression. $10 gift cards are provided for each survey completed.